FGFR2-TSC22D1, a novel FGFR2 fusion gene identified in a patient with colorectal cancer: A case report

BACKGROUND: The FGFR signaling pathway is activated in multiple tumor types through gene amplifications, single base substitutions, or gene fusions. Novel FGFR gene fusions may represent candidate targets for the development of tyrosine kinase inhibitors. CASE SUMMARY: Herein, we report a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Xiao-Ming, Zhu, Xi, Zhang, Jun-Ling, Chen, Shi-Qing, Fan, Chao-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362506/
https://www.ncbi.nlm.nih.gov/pubmed/34447836
http://dx.doi.org/10.12998/wjcc.v9.i23.6867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362506/
https://www.ncbi.nlm.nih.gov/pubmed/34447836
http://dx.doi.org/10.12998/wjcc.v9.i23.6867

Ejemplares similares